Citation: Nr. Hartman et al., THE IN-VITRO METABOLISM OF PENCLOMEDINE IN MOUSE, RAT, AND HUMAN SYSTEMS, Drug metabolism and disposition, 26(6), 1998, pp. 513-519
Authors:
KAPETANOVIC IM
TORCHIN CD
THOMPSON CD
MILLER TA
MCNEILLY PJ
MACDONALD TL
KUPFERBERG HJ
PERHACH JL
SOFIA RD
STRONG JM
Citation: Im. Kapetanovic et al., POTENTIALLY REACTIVE CYCLIC CARBAMATE METABOLITE OF THE ANTIEPILEPTICDRUG FELBAMATE PRODUCED BY HUMAN LIVER-TISSUE IN-VITRO, Drug metabolism and disposition, 26(11), 1998, pp. 1089-1095
Authors:
VANZIJL PCM
DAVIS D
ELEFF SM
MOONEN CTW
PARKER RJ
STRONG JM
Citation: Pcm. Vanzijl et al., DETERMINATION OF CEREBRAL GLUCOSE-TRANSPORT AND METABOLIC KINETICS BYDYNAMIC MR SPECTROSCOPY, American journal of physiology: endocrinology and metabolism, 36(6), 1997, pp. 1216-1227
Authors:
MOODY DE
ALBURGES ME
PARKER RJ
COLLINS JM
STRONG JM
Citation: De. Moody et al., THE INVOLVEMENT OF CYTOCHROME-P450-3A4 IN THE N-DEMETHYLATION OF L-ALPHA-ACETYLMETHADOL (LAAM), NORLAAM, AND METHADONE, Drug metabolism and disposition, 25(12), 1997, pp. 1347-1353
Authors:
MCNEILLY PJ
TORCHIN CD
ANDERSON LW
KAPETANOVIC IM
KUPFERBERG HJ
STRONG JM
Citation: Pj. Mcneilly et al., IN-VITRO GLUCURONIDATION OF D-23129, A NEW ANTICONVULSANT, BY HUMAN LIVER-MICROSOMES AND LIVER SLICES, Xenobiotica, 27(5), 1997, pp. 431-441
Authors:
LUDDEN LK
LUDDEN TM
COLLINS JM
PENTIKIS HS
STRONG JM
Citation: Lk. Ludden et al., EFFECT OF ALBUMIN ON THE ESTIMATION, IN-VITRO, OF PHENYTOIN V-MAX ANDK-M VALUES - IMPLICATIONS FOR CLINICAL CORRELATION, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 391-396
Authors:
WAUD WR
TIWARI A
SCHMID SM
SHIH TW
STRONG JM
HARTMAN NR
OREILLY S
STRUCK RF
Citation: Wr. Waud et al., 4-DEMETHYLPENCLOMEDINE, AN ANTITUMOR-ACTIVE, POTENTIALLY NONNEUROTOXIC METABOLITE OF PENCLOMEDINE, Cancer research, 57(5), 1997, pp. 815-817
Authors:
ANDERSON LW
CHEN TL
COLVIN OM
GROCHOW LB
COLLINS JM
KENNEDY MJ
STRONG JM
Citation: Lw. Anderson et al., CYCLOPHOSPHAMIDE AND 4-HYDROXYCYCLOPHOSPHAMIDE ALDOPHOSPHAMIDE KINETICS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE CHEMOTHERAPY/, Clinical cancer research, 2(9), 1996, pp. 1481-1487
Authors:
TORCHIN CD
MCNEILLY PJ
KAPETANOVIC IM
STRONG JM
KUPFERBERG HJ
Citation: Cd. Torchin et al., STEREOSELECTIVE METABOLISM OF A NEW ANTICONVULSANT DRUG CANDIDATE, LOSIGAMONE, BY HUMAN LIVER-MICROSOMES, Drug metabolism and disposition, 24(9), 1996, pp. 1002-1008
Citation: Rj. Parker et al., IDENTIFICATION OF 2,6-XYLIDINE AS A MAJOR LIDOCAINE METABOLITE IN HUMAN LIVER SLICES, Drug metabolism and disposition, 24(11), 1996, pp. 1167-1173
Authors:
LUDDEN LK
PENTIKIS HS
LUDDEN TM
COLLINS JM
STRONG JM
Citation: Lk. Ludden et al., THE ADDITION OF ALBUMIN, IN-VITRO, YIELDS MEANINGFUL FREE DRUG KM VALUES FOR PHENYTOIN METABOLISM, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 45-45
Authors:
ANDERSON LW
LUDEMAN SM
COLVIN OM
GROCHOW LB
STRONG JM
Citation: Lw. Anderson et al., QUANTITATION OF 4-HYDROXYCYCLOPHOSPHAMIDE ALDOPHOSPHAMIDE IN WHOLE-BLOOD, Journal of chromatography B. Biomedical applications, 667(2), 1995, pp. 247-257
Citation: Lk. Ludden et al., SIMILARITY OF METABOLISM FOR CAI (NSC-609974) IN HUMAN LIVER-TISSUE IN-VITRO AND IN HUMANS IN-VIVO, Clinical cancer research, 1(4), 1995, pp. 399-405
Authors:
LUDEMAN SM
SHULMANROSKES EM
WONG KKT
HAN SY
ANDERSON LW
STRONG JM
COLVIN OM
Citation: Sm. Ludeman et al., OXIME DERIVATIVES OF THE INTERMEDIARY ONCOSTATIC METABOLITES OF CYCLOPHOSPHAMIDE AND IFOSFAMIDE - SYNTHESIS AND DEUTERIUM LABELING FOR APPLICATIONS TO METABOLITE QUANTIFICATION, Journal of pharmaceutical sciences, 84(4), 1995, pp. 393-398
Authors:
MCLACHLAN BG
BELL JH
PARK H
KENNELLY RA
SCHREINER JA
SMITH SC
STRONG JM
GALLERY J
GOUTERMAN M
Citation: Bg. Mclachlan et al., PRESSURE-SENSITIVE PAINT MEASUREMENTS ON A SUPERSONIC HIGH-SWEEP OBLIQUE WING MODEL, Journal of aircraft, 32(2), 1995, pp. 217-227
Authors:
STRONG JM
MOODY DE
PARKER RJ
ALBURGES ME
COLLINS JM
Citation: Jm. Strong et al., PROTOCOL FOR INVESTIGATING P450 METABOLISM OF L-ALPHA-ACETYLMETHADOL (LAAM) IN HUMAN LIVER-TISSUE IN-VITRO, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 148-148
Citation: Rj. Parker et al., METABOLISM OF LIDOCAINE IN HUMAN LIVER SLICES AND LIVER-MICROSOMES - IDENTIFICATION OF 2,6-XYLIDINE AS A MAJOR METABOLITE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 211-211
Authors:
TAKIMOTO CH
KLECKER RW
DAHUT WL
YEE LK
STRONG JM
ALLEGRA CJ
GREM JL
Citation: Ch. Takimoto et al., ANALYSIS OF THE ACTIVE LACTONE FORM OF 9-AMINOCAMPTOTHECIN IN PLASMA USING SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 655(1), 1994, pp. 97-104
Authors:
TAKIMOTO CH
VOELLER DB
STRONG JM
ANDERSON L
CHU E
ALLEGRA CJ
Citation: Ch. Takimoto et al., EFFECTS OF 5-FLUOROURACIL SUBSTITUTION ON THE RNA CONFORMATION AND IN-VITRO TRANSLATION OF THYMIDYLATE SYNTHASE MESSENGER-RNA, The Journal of biological chemistry, 268(28), 1993, pp. 21438-21442